Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62020TN0484

Case T-484/20: Action brought on 3 August 2020 — SATSE v Commission

IO C 304, 14.9.2020, p. 25–25 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Date of document:
03/08/2020
Date lodged:
03/08/2020
Author:
Cúirt Ghinearálta
Form:
Faisnéis bhreithiúnach
Authentic language:
Spáinnis
Type of procedure:
Caingean le haghaidh neamhniú
Link
Select all documents mentioning this document
Case affecting:
Instruments cited in case law:
Link

14.9.2020   

EN

Official Journal of the European Union

C 304/25

Action brought on 3 August 2020 — SATSE v Commission

(Case T-484/20)

(2020/C 304/29)

Language of the case: Spanish

Parties

Applicant: Sindicato de Enfermería (SATSE) (Madrid, Spain) (represented by: M. Sesmero González, lawyer)

Defendant: European Commission

Form of order sought

The applicant claims that the General Court should:

—

Annul Commission Directive (EU) 2020/739 of 3 June 2020 amending Annex III to Directive 2000/54/EC of the European Parliament and of the Council as regards the inclusion of SARS-CoV-2 in the list of biological agents known to infect humans and amending Commission Directive (EU) 2019/1833, published in the Official Journal of the European Union of 4 June 2020 (OJ 2020 L 175, p. 11).

Pleas in law and main arguments

In support of the action, the applicant relies on two pleas in law.

1.

First plea in law, alleging infringement of Articles 2 and 18 of Directive 2000/54/EC and Annex III thereto.

—

In that regard, the applicant relies on the absence of any effective treatment or prophylaxis for the biological agent SARS-CoV-2, the fact that it is a virus that is considered to be highly contagious and which mutates and, therefore, is highly likely to spread to the community and the fact that the coronavirus SARS-CoV-2 causes serious conditions and symptoms resulting in severe human disease, presenting a serious hazard to workers.

2.

Second plea in law, alleging infringement of essential procedural requirements on account of the failure to state reasons for the classification of the biological agent SARS-CoV-2 in group 3.

—

In that regard, the applicant submits that although the Commission acknowledged that there was no vaccine or effective treatment and despite what was provided for in Article 2 of Directive 2000/54/EC, it classified SARS-CoV-2 in risk group 3 rather than in risk group 4.
Top